Houston, TX – 10/05/2020. The DermaClip® skin closure device has been named an R&D 100 Award Winner for 2020, recognizing its innovative contribution to wound closure.
Charles Darling, CEO, in commenting on the award, stated: “This is great recognition for the device. Being selected in 2020 as one of the top 100 innovations to be recognized this year, we believe the award demonstrates the tremendous innovation this device brings in medical technology generally and in wound closure specifically. We are honored by the recognition."
DermaClip® aims to optimize incision, laceration and wound repair through non-invasive, cost-effective and efficiency-producing skin closure devices. Named an R&D 100 winner as one of the 100 top innovations in 2020, the DermaClip device is a non-invasive skin closure device that is an alternative to sutures, surgical staples and glues. The device aims to improve the patient experience while reducing the time and cost burden of closure by transforming a highly variable skill into a reproducible process. The device has been used in more than 30,000 cases, everywhere from in the field to the Emergency Department to the surgical suite. The DermaClip team believes that high quality skin closure should be available to everyone, regardless of access to high-end services. The team aims to eliminate the trade-offs in skin closure made between time of closure and quality of patient care. DermaClip is headquartered in Houston, TX. For more information, visit the DermaClip website. You can also find more about the DermaClip devices on Twitter, Facebook, LinkedIn, and Instagram.
About the R&D 100 Awards
Established in 1963, the R&D 100 Awards is the only S&T (science and technology) awards competition that recognizes new commercial products, technologies and materials for their technological significance that are available for sale or license. For more information, visit the R&D 100 Winners, 2020.